These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 28216662)
1. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway. Du C; Li DQ; Li N; Chen L; Li SS; Yang Y; Hou MX; Xie MJ; Zheng ZD Sci Rep; 2017 Feb; 7():42876. PubMed ID: 28216662 [TBL] [Abstract][Full Text] [Related]
2. miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway. Wu N; Han Y; Liu H; Jiang M; Chu Y; Cao J; Lin J; Liu Y; Xu B; Xie X Biochem Biophys Res Commun; 2018 Sep; 503(3):1491-1497. PubMed ID: 30029874 [TBL] [Abstract][Full Text] [Related]
3. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway. Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035 [TBL] [Abstract][Full Text] [Related]
4. DDX21 promotes gastric cancer proliferation by regulating cell cycle. Cao J; Wu N; Han Y; Hou Q; Zhao Y; Pan Y; Xie X; Chen F Biochem Biophys Res Commun; 2018 Nov; 505(4):1189-1194. PubMed ID: 30322617 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer. Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MIAT promotes gastric cancer growth and metastasis through regulation of miR-141/DDX5 pathway. Sha M; Lin M; Wang J; Ye J; Xu J; Xu N; Huang J J Exp Clin Cancer Res; 2018 Mar; 37(1):58. PubMed ID: 29540201 [TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5. Wu N; Jiang M; Han Y; Liu H; Chu Y; Liu H; Cao J; Hou Q; Zhao Y; Xu B; Xie X J Cell Mol Med; 2019 Feb; 23(2):1354-1362. PubMed ID: 30484950 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer. Ma Z; Feng J; Guo Y; Kong R; Ma Y; Sun L; Yang X; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Cheng Y; Zha D; Liu S Oncol Res; 2017 Jul; 25(6):887-895. PubMed ID: 28244855 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-224 aggrevates tumor growth and progression by targeting mTOR in gastric cancer. Zhang Y; Li CF; Ma LJ; Ding M; Zhang B Int J Oncol; 2016 Sep; 49(3):1068-80. PubMed ID: 27315344 [TBL] [Abstract][Full Text] [Related]
10. RNA helicase DDX5-induced circPHF14 promotes gastric cancer cell progression. Wang J; Han C; Wang J; Peng Q Aging (Albany NY); 2023 Mar; 15(7):2525-2540. PubMed ID: 36996491 [TBL] [Abstract][Full Text] [Related]
11. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway. Li Z; Li Y; Jia Y; Ding B; Yu J Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637 [TBL] [Abstract][Full Text] [Related]
12. DDX5 Silencing Suppresses the Migration of Basal cell Carcinoma Cells by Downregulating JAK2/STAT3 Pathway. Quan Z; Zhang BB; Yin F; Du J; Zhi YT; Xu J; Song N Technol Cancer Res Treat; 2019; 18():1533033819892258. PubMed ID: 31870221 [TBL] [Abstract][Full Text] [Related]
13. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway. Xue Y; Jia X; Li L; Dong X; Ling J; Yuan J; Li Q Biochem Biophys Res Commun; 2018 Sep; 503(4):2885-2891. PubMed ID: 30119889 [TBL] [Abstract][Full Text] [Related]
14. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway. Ma X; Guo P; Qiu Y; Mu K; Zhu L; Zhao W; Li T; Han L Oncotarget; 2016 Jun; 7(24):36185-36197. PubMed ID: 27167192 [TBL] [Abstract][Full Text] [Related]
15. ESCO2 knockdown inhibits cell proliferation and induces apoptosis in human gastric cancer cells. Chen H; Zhang L; He W; Liu T; Zhao Y; Chen H; Li Y Biochem Biophys Res Commun; 2018 Feb; 496(2):475-481. PubMed ID: 29330052 [TBL] [Abstract][Full Text] [Related]
16. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer. Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874 [TBL] [Abstract][Full Text] [Related]
17. PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation. Yu S; Li L; Wu Q; Dou N; Li Y; Gao Y Int J Oncol; 2018 Jun; 52(6):2011-2020. PubMed ID: 29568966 [TBL] [Abstract][Full Text] [Related]
18. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434 [TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506 [TBL] [Abstract][Full Text] [Related]
20. Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling. Dou N; Yu S; Ye X; Yang D; Li Y; Gao Y Oncotarget; 2016 Dec; 7(52):86161-86173. PubMed ID: 27863387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]